What a Chinese Lymphoma Review Actually Needs From Your Home Team
Lymphoma is not one disease. Hodgkin and non-Hodgkin types behave differently, and the exact subtype changes which treatments are discussed. A Chinese clinician reviewing your case cannot move to the next treatment step without knowing what your home team already diagnosed and how your disease responded. The review is a records-based opinion, not a diagnosis made from scratch.
The practical question is not 'send everything.' It is 'send what answers the question being asked.' If the question is whether the next line of treatment should change, the Chinese reviewer needs the pathology report that names the subtype, the treatment history with regimens and dates, and the imaging or biopsy results that show response. If the question is about monitoring or admission needs, the reviewer also needs current blood counts, organ function and any active symptoms.
Your home team is the source of truth for your treatment so far. The Chinese team is being asked for an opinion on the next step. The exchange works best when both sides understand that division. Ask your home oncologist to write a short summary letter that states the diagnosis, the treatment given, the response, and the specific question you want answered. That letter, plus the underlying reports, is more useful than a folder of unlabelled scans.
The Records That Change the Next Treatment Decision
Pathology is the first record to confirm. The report should name the lymphoma subtype and note any markers or classification that your home team used. If the original pathology was reviewed or reclassified, include both versions. A Chinese reviewer who sees only 'lymphoma' cannot judge whether a treatment is appropriate.
Treatment history is the second. For each regimen, the home team should provide the drug names, the dates of each cycle, and any dose reductions or delays. Response assessment is the third. This means the imaging reports and, where available, the biopsy or PET findings that your home team used to decide whether the treatment worked. A summary that says 'good response' is less useful than the actual report.
Current status is the fourth. Recent blood counts, liver and kidney function, and any infection or symptom that is active now. If your home team has already planned the next step, say what that plan is and why. The Chinese reviewer needs to know what decision is actually open, not just what happened in the past.
You do not need to translate everything yourself. Ask the hospital or your coordination contact what format they prefer and whether they need certified translations. The key is that the clinical content is legible to the reviewer. A clear summary from your home oncologist, in English, with the original reports attached, is often enough to start.
How to Ask Your Home Team for a Handover Summary
A handover summary is not a favour. It is a clinical document that your home team can prepare for any second opinion. Ask for it in writing and keep it short. It should state the diagnosis, the treatment given, the response, the current problem, and the question you want the Chinese team to answer. If your home team disagrees with the idea of a review in China, ask them to state their concerns in the same letter. That is useful information, not an obstacle.
Ask your home team what they would need from a Chinese hospital before they would change their own plan. This flips the exchange. Instead of only sending records out, you learn what your home team considers decisive. If they say they would need a repeat biopsy or a specific molecular test, you can ask the Chinese hospital whether that is part of the review or a separate step.
Keep the exchange documented. Note what you sent, to whom, and when. If a report is missing, ask your home team to send it directly to the Chinese hospital if they are willing, or to give you a copy. Do not assume that a verbal summary over the phone will reach the reviewer. The clinical record needs to be in the file.
What the Chinese Team Should Send Back
A records-based review should produce a written opinion that states what the reviewer understood, what records were available, what is missing, and what the reviewer recommends or cannot yet recommend. It should distinguish between a review of the records and a decision that requires you to be examined in person. It should not promise that a treatment is available, that you will be admitted, or that a particular regimen will be used.
Ask the Chinese team to state any assumptions they made. If they reviewed your case without a recent scan, they should say so. If they think a test is needed before a recommendation, they should name the test and explain what it would change. This makes the opinion useful to your home team, who can then decide whether to act on it.
If the Chinese team suggests a treatment that is not available where you live, ask them to explain the evidence and the alternatives. A recommendation is not the same as access. Your home team remains responsible for your care unless you formally transfer it. The Chinese opinion is one input into that decision.
Admission and Monitoring Questions to Confirm Before Travel
If the review leads to a discussion about treatment in China, the next questions are practical. Would you need to be admitted, and for what? What monitoring would be required during treatment? Who would manage complications? What would happen if you needed to return home? These are questions for the Chinese hospital, not assumptions you can make from a general guide.
Ask the hospital what records it needs before it can confirm an appointment or an admission. Ask whether the review can be done remotely first, and what would still require an in-person visit. Ask what the written estimate or plan would include, and what would be arranged separately. Do not treat a preliminary reply as a confirmed plan.
Your home team should stay involved. If you travel, ask who will receive updates and how. Ask the Chinese hospital to send clinical summaries back to your home oncologist. A treatment decision made in China without your home team's knowledge can create gaps when you return. The exchange of records should continue after travel, not stop at the first review.
Next Step: Start With the Question, Not the Whole File
You do not need to assemble a complete medical archive before making an enquiry. Start with a short summary: the subtype, the treatments already given, the response, and the specific question you want answered. ChinaSpecialistCare can help request a specialist appointment or a records-based review, and can arrange interpretation and practical support if you travel. The hospital decides whether it can accept your case and what it needs.
Send the summary first. The team will tell you what is missing and what the relevant next step is. An initial enquiry is free and does not require buying a proxy consultation. If you already have a pathology report and a treatment summary, include them. If you do not, say so. The review can begin with what you have, and the gaps can be clarified as you go.
Keep your home team informed at every stage. The goal is not to replace them. It is to give both sides the same accurate picture so the next treatment decision is made with the best available information.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.